
CLAIRITY BREAST: First A.I. tool authorized by FDA to predict 5-year breast cancer risk.
Failed to add items
Add to Cart failed.
Add to Wish List failed.
Remove from wishlist failed.
Adding to library failed
Follow podcast failed
Unfollow podcast failed
-
Narrated by:
-
By:
#DoctorPodcasts Episode 117:
Breast cancer kills 42,000+ women in the USA annually. Connie Lehman, MD, PhD & Jeff Luber, JD, MBA of CLAIRITY, Inc. have received FDA authorization for the first A.I.-powered mammography tool - CLAIRITY BREAST - that predicts 5-year cancer risk. It will save many lives. For details go to Clairity.com
Watch all 117 DoctorPodcasts || Cykiert Files video podcast interview episodes with physicians, scientists, healthcare specialists, entrepreneurs and other experts. Please SUBSCRIBE & FOLLOW @DoctorPodcasts. Please LIKE, REPOST/QUOTE and SHARE the episodes. Send questions, comments and messages to @DoctorPodcasts. Thank you. Robert Cykiert, M.D.
#BreastCancerPrediction
#FDAuthorizedAI
#ClairityBreast
#ArtificialIntelligence
#MammographyTool
#CancerRiskPrediction
#WomensHealth
#MedicalInnovation
#HealthcareTechnology
#DoctorPodcasts
#CykiertFiles
#Episode117
#ConnieLehman
#JeffLuber
#CLAIRITYInc
#FiveYearRisk
#EarlyDetection
#PersonalizedMedicine
#AIinHealthcare
#BreastCancerAwareness
#MedicalPodcasts
#HealthcareExperts
#InnovationInMedicine
#TechInHealthcare
#RiskAssessment
#PreventiveHealthcare
#DigitalHealth
#MedicalResearch
#ClinicalOncology
#ASCO2025
#FDAApproval
#HealthTech
#PrecisionMedicine
#CancerPrevention
#MammogramScreening
#AIHealthcareSolutions
#FutureOfMedicine
#HealthInnovation
#MedicalBreakthroughs
#PatientCare
#RobertCykiert
#RobertCykiertMD